Quickly sort and find the exact file you need here. Send the files directly into your Shareholder Briefcase or read and right click "save target as" individual files.
|Fact Sheet||372.0 KB|
|2013 Annual Report||2013||754.1 KB|
|2013 10-K||2013||1.0 MB|
|2012 10-K||2012||1.0 MB|
|2011 10-K||2011||1.1 MB|
|2010 10-K||2010||1.0 MB|
|Charter of the Compensation Committee||154.3 KB|
|2009 10-K||2009||2.0 MB|
|Charter of the Audit Committee||97.1 KB|
|Charter of the Nominating and Governance Committee||42.7 KB|
- Corporate Governance
- Management & Board
- Stock Information
- SEC Filings
- Quarterly Results
- Analyst Coverage
- Webcasts & Presentations
- Scientific Publications & Presentations
- Frequently Asked Questions
© 2004-2014 OncoGenex Pharmaceuticals Inc. All rights reserved.
OncoGenex product candidates are investigational drugs for use only in approved clinical trials.
OncoGenex Pharmaceuticals is a drug discovery and development company uniquely focused on the challenge of cancer treatment resistance.
OncoGenex is uniquely focused on the challenge of cancer treatment resistance. We currently have several on-going clinical trials that may be of interest to you.
OncoGenex focuses on diverse molecular entities that target mechanisms of resistance and that have the potential to re-define treatment paradigms in a variety of cancers.
OncoGenex develops novel compounds designed to meet the persistent challenge of treatment resistance across a variety of cancers.